Tesamorelin
A synthetic, N-terminally modified analogue of growth hormone-releasing hormone (GHRH). Utilized to investigate targeted visceral adipose reduction pathways and basal growth hormone pulsatility.
$128.00
Size / Spec: 5mg / vial
Format: Lyophilized Powder
CAS Number: 218949-48-5
Chemical Formula: C170H277N51O55
Molecular Wt.: 3914.4 g/mol
Out of stock
Storage Instructions
In lyophilized form, store at -20°C to 4°C. Keep away from light. If reconstituted, refrigerate.
Mandatory Disclaimer
For Research Use Only. Not for human or animal consumption.
Money Back Guarantee
Satisfaction Guarantee
Easy Returns
Secure Ordering
Product Features
- N-terminally modified GHRH analogue
- High affinity for pituitary GHRH receptors
- Enhanced resistance to dipeptidyl peptidase-4 (DPP-4) cleavage
- Suitable for in vitro preclinical research
- Greater than 99% pure HPLC
Products you may like
Semax
A synthetic heptapeptide analogue derived from adrenocorticotropic hormone (ACTH 4-10). Utilized to investigate BDNF/NGF expression, neuroprotection, and cognitive pathway modulation.
Melanotan 2
A synthetic, cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone (α-MSH). Utilized to investigate non-selective melanocortin receptor agonism, melanogenesis, and neuro-arousal pathways.
PT-141
A synthetic peptide (Bremelanotide) acting as a potent, non-selective agonist of the melanocortin receptors. Utilized to investigate central nervous system…
CJC-1295 + Ipamorelin
A synergistic co-formulation of a GHRH analogue and a selective GHSR-1a agonist. Utilized to investigate amplified, pulsatile growth hormone secretion…